HR was noted to be 120 with BP 93/60 ( his nl 110-120 SBP).
EKG showed HR 180-220s and a fib.
He received cefepime 2g IV x1, vancomycin 1 gram x1, 3L of IVF (with good UOP), and blood cx x2.
CXR noted port to be terminating in the mid SVC.
Vitals prior to transfer to the floor were 117/80 (neo at 3) HR 170s 16 99%.
On arrival to the floor VS were 99.2 150/100 HR 170 RR15 99% RA.
He had a WBC count of 94.8K (N0 L13, Blasts 87%).
Bone marrow examination following treatment demonstrated a hypercellular marrow (80-90%) with megakaryocytic hyperplasia and clustering, and diagnostic morphologic features of involvement by acute leukemia were not seen.
Physical Exam: Gen: unwell, fatigued, pale compared with prior examinations HEENT: PERRL, EOMI, OP clear, MM dry with thick coating Skin: mild rash on the back of his neck, but otherwise, no evidence of GVH Chest: line c/d/i, right chest--not erythematous or tender Car: Irregular, tachycardic Resp: clear to auscultation bilaterally Abd: soft, not tender, not distended, no HSM Ext: no LE edema Back: no midline tenderness   Pertinent Results: [**2147-11-23**] 09:35AM   GRAN CT-[**Numeric Identifier 70565**]* [**2147-11-23**] 09:35AM   PLT COUNT-115* [**2147-11-23**] 09:35AM   NEUTS-89.8* LYMPHS-4.1* MONOS-5.7 EOS-0.2 BASOS-0.1 [**2147-11-23**] 09:35AM   WBC-13.1* RBC-3.85* HGB-13.4* HCT-38.0* MCV-99* MCH-34.8* MCHC-35.3* RDW-19.9* [**2147-11-23**] 09:35AM   CYCLSPRN-277 [**2147-11-23**] 09:35AM   TSH-0.29 [**2147-11-23**] 09:35AM   CALCIUM-8.5 PHOSPHATE-4.2 MAGNESIUM-1.7 [**2147-11-23**] 09:35AM   ALT(SGPT)-85* AST(SGOT)-34 ALK PHOS-63 TOT BILI-1.2 [**2147-11-23**] 09:35AM   UREA N-29* CREAT-1.2 SODIUM-134 POTASSIUM-4.3 CHLORIDE-101 TOTAL CO2-21* ANION GAP-16 [**2147-11-23**] 11:17AM   HGB-13.4* calcHCT-40 [**2147-11-23**] 11:17AM   GLUCOSE-123* LACTATE-1.5 NA+-137 K+-4.4 CL--104 TCO2-24  CXR: IMPRESSION: No acute intrathoracic process.
He underwent TEE which was negative for clot and then had DCCV Cardioversion wtih 200 J X 1 with conversion to normal sinus rhythm.
Following cardioversion, his blood pressure returned to [**Location 213**] and pressors/diltiazem were stopped.
Echocardiogram did not demonstrate structural abnormalities to his heart, TSH was normal, electrolytes were normal.
He was treated empirically with antibiotics (Cefepime/Vancomycin) and cultures were taken.
He was then transfered to [**Location 3242**] for further evaluation.
He was placed on tele, and it was noted that his resting HR was in sinus in the high 90's to 100's.
After discussing his sinus tachycardia with the cardiology fellow, he was sent for a CTA which did not demonstrate any pulmonary embolism.
Blood cultures and a urine culture from the time of his admission to discharge were negative for any growth.
Release 24 hr - 1 Capsule(s) by mouth three times per day CYCLOSPORINE MODIFIED -  (Dose adjustment - no new Rx) - 25 mg Capsule - 2 Capsule(s) by mouth twice daily Total dose is 150 mg [**Hospital1 **] - No Substitution CYCLOSPORINE MODIFIED [NEORAL] - 100 mg Capsule - 1 Capsule(s) by mouth twice dailyFOLIC ACID - 1 mg Tablet - 1 Tablet(s) by mouth daily LORAZEPAM [ATIVAN] - 0.5 mg Tablet - [**1-21**] Tablet(s) by mouth every 6 hours as needed as needed for nausea, insomnia PREDNISONE 15mg qam and 20mg qpm SULFAMETHOXAZOLE-TRIMETHOPRIM - 400 mg-80 mg Tablet - 1 Tablet(s) by mouth daily URSODIOL - 300 mg Capsule - [**1-21**] Capsule(s) by mouth twice daily as directed take 300 mg (1 tab) every morning, take 600 mg (2 tab) every evening VORICONAZOLE [VFEND] - 200 mg Tablet - 1 Tablet(s) by mouth twice a day MAGNESIUM OXIDE-MG AA CHELATE [MG-PLUS-PROTEIN] - 133 mg Tablet - [**1-21**] Tablet(s) by mouth three times a day to be adjusted by physician [**Name Initial (PRE) 26391**] -  (OTC) -   Capsule - 1 Capsule(s) by mouth once a day   Discharge Medications: 1. acyclovir 400 mg Tablet Sig: One (1) Tablet PO three times a day.
Release 24 hr Sig: One (1) Capsule, Sust.
Release 24 hr PO TID (3 times a day).
You were treated with antibiotics in case there was an infectious cause, but your cultures were negative.
Followup Instructions: Provider: [**Name10 (NameIs) 3242**] [**Apartment Address(1) 1246**] [**Apartment Address(1) 3242**] CHAIRS & ROOMS Date/Time:[**2147-11-27**] 8:30 Provider: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 13863**], RN Phone:[**Telephone/Fax (1) 3241**] Date/Time:[**2147-11-27**] 8:30 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 3749**], MD Phone:[**Telephone/Fax (1) 3241**] Date/Time:[**2147-11-27**] 9:30    Completed by:[**2147-11-27**
